Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
REalloys Inc. has received a memorandum from the Department of War emphasizing the urgent national security need to secure domestic heavy rare earth elements (HREE), particularly Dysprosium and Terbium, ahead of a 2027 ban on Chinese-origin rare earth materials. REalloys is developing the largest heavy rare earth metallization facility outside Chin…
U.S. airline stocks rose sharply after reports that the United States and Iran are close to a one-page memorandum intended to end hostilities and open negotiations on a detailed settlement. The move reduced perceived geopolitical risk, sending Brent crude to a two-week low and lifting major carriers by roughly 5% to 7.6%.
ON Semiconductor Corporation announced a proposed private offering of $1.3 billion aggregate principal amount of Convertible Senior Notes due 2031, with an option for an additional $200 million. The proceeds will be used to pay for convertible note hedge transactions, repurchase up to $400 million of common stock, repay debt, and fund general corpo…
Cal‑Maine (CALM) is the largest U.S. producer of shell eggs and is trading like a cyclical producer at the trough. Recent quarter showed sharply lower sales and earnings as egg prices normalized, but the company's balance sheet, free cash flow and strategic moves (Creighton acquisition, specialty egg mix) argue for a recovery. Valuation is compelli…
X4 Pharmaceuticals announced its Q1 2026 financial results and provided corporate updates highlighting the on-track enrollment completion of its global Phase 3 4WARD trial for mavorixafor in chronic neutropenia by end of Q3 2026. The company also celebrated European Commission approval of XOLREMDI® for WHIM syndrome, marking the first authorized tr…
The New York Times reported net gains in digital-only subscribers that exceeded analyst projections, driven by elevated news consumption amid geopolitical tensions and policy shifts. The company continues to emphasize subscription-led growth and bundled product offerings, and its shares rose in early trading following the announcement.
Sprouts (SFM) looks like a pragmatic long: trading around $79 with a market cap near $7.4B, the stock sits at ~15x forward earnings with healthy free cash flow and a conservative balance sheet. Weak comps and macro sensitivity leave near-term volatility, but management’s buybacks, raised guidance, and store expansion roadmap create a credible path …
Instacart, legally Maplebear, projected second-quarter gross transaction value above consensus and reported stronger-than-expected first-quarter results, driven by both price-sensitive and higher-income shoppers. The company signaled resilience in consumer spending despite macroeconomic uncertainty and emphasized affordability amid potential cost p…
Lifecore Biomedical announced its financial results for Q1 2026, showing a 34% decline in revenue to $23.2 million and a net loss of $15.0 million. Despite top-line challenges, the company implemented cost containment strategies reducing operating expenses by 52%, launched a new ERP system to improve efficiencies, signed three new commercial site t…
TransAlta reported first quarter 2026 results showing strong operational availability and cash flow despite softer Alberta power prices and lower production. The company reaffirmed its 2026 outlook, announced leadership changes, strategic moves in data center development, acquisition of Far North assets, and increased its dividend by 8%. However, a…
Uber Technologies projected second-quarter gross bookings that exceed Wall Street consensus, driven by robust demand in ride-hailing and delivery, expanded international traction and gains from its membership program. Management factored in a roughly 60 basis-point drag from the Middle East conflict while highlighting AI adoption and a push into hi…
Atlas, supported by CoinMarketCap, is assuming responsibility for the price feeds and data delivery services previously run by Binance Oracle across BNB Chain, opBNB and other applicable networks. A 90-day migration window has begun; Atlas offers protocol-level configurability, access to CoinMarketCap’s aggregated pricing from over 905 sources, and…
TScan Therapeutics reported Q1 2026 financial results along with a major corporate update highlighting important upcoming milestones. The company plans initiation of a Phase 3 study for its lead TCR-T therapy candidate TSC-101 in Q2 2026 and expects early data from the ALLOHA Phase 1 trial. Further, Phase 1 studies for new candidates TSC-102-A01 an…
Kamada Ltd., a global biopharmaceutical company specializing in plasma-derived therapies, announced it will release its first quarter 2026 financial results on May 13, 2026, prior to U.S. market open. Management will host a conference call to discuss these results and provide updates on the company's operations and growth strategies.
Marex Group plc, listed on Nasdaq under the ticker MRX, announced record financial results for Q1 2026, highlighting substantial revenue and profit growth across all business segments. The diversified financial services firm benefited from elevated market volatility, strong client demand, and strategic acquisitions, leading to a 48% increase in rev…
Immunocore Holdings plc reported a 14% year-over-year increase in Q1 2026 net sales of its lead product, KIMMTRAK, reaching $106.7 million globally. Landmark five-year survival data presented at AACR 2026 demonstrated that KIMMTRAK doubles the likelihood of survival in metastatic uveal melanoma patients. The company is progressing multiple Phase 3 …
EyePoint, Inc. announced its first quarter 2026 financial results highlighting ongoing Phase 3 clinical trials for its lead product candidate DURAVYU in wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The company expects topline data for wet AMD trials starting mid-2026 and anticipates completing enrollment for DME …
BioCryst Pharmaceuticals announced its first quarter 2026 financial results highlighting an 11% year-over-year increase in net revenue for ORLADEYO to $148.3 million. The company also revealed a $70 million upfront licensing agreement with Neopharmed Gentili for the European commercial rights to navenibart, with potential milestone payments up to $…
Energous Corporation, a Nasdaq-listed leader in over-the-air wireless power networks, announced its participation in a fireside chat at Planet MicroCap Las Vegas 2026. The event will feature key executives discussing the company’s strategy and growth, providing an opportunity for investor engagement and visibility in the microcap community.
Kymera Therapeutics, a clinical-stage biotech company focused on targeted protein degradation therapies for immunological diseases, announced participation in two upcoming investor conferences in May 2026. The company will hold fireside chats at the Bank of America and RBC Capital Markets healthcare conferences, with live webcasts available on thei…
Geron Corporation announced an 8% increase in net revenue for its approved blood cancer drug RYTELO in Q1 2026 compared to Q4 2025, driven by higher demand and expanded ordering accounts. The company reaffirmed its 2026 revenue and expense guidance, highlighted progress in European commercial strategy and clinical trials, and strengthened its leade…
Sprott Inc. reported a 9% increase in Assets Under Management (AUM) to $65.1 billion for Q1 2026, driven by market appreciation and net inflows, especially in precious metals and critical materials funds. Revenues and net income significantly increased compared to Q1 2025, supported by higher management fees, carried interest, and ETF expansion, in…
KVH Industries announced its Q1 2026 results with revenues up 27% year-over-year to $32.3 million, driven primarily by a 30% increase in service revenue led by growth in low Earth orbit (LEO) satellite service sales from Starlink and OneWeb. The company reported a net income of $0.6 million, compared to a loss in the prior year period, and a substa…
U.S. Energy Corp. (NASDAQ: USEG) has been selected to participate in the inaugural Emerging Company Pavilion at the 31st Annual Sohn Investment Conference on May 12, 2026. This selection recognizes the company's growth trajectory and market potential, offering exposure to leading institutional investors and enhancing its profile in helium, carbon m…
Tonix Pharmaceuticals announced an agreement with a major group purchasing organization to provide commercial payer coverage for TONMYA® (cyclobenzaprine HCl sublingual tablets), a first-in-class FDA-approved non-opioid treatment for fibromyalgia in adults. The agreement grants access to around 35 million commercial lives in the U.S., representing …
